Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Baron CS"'
Autor:
Baron CS, Mitchell O, Avagyan S, Menard R, Yang S, Robertson AL, Potluri R, Shendure J, Madelaine R, McKenna A, Zon LI
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Sep 13. Date of Electronic Publication: 2024 Sep 13.
Autor:
Noonan HR; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Boston, United States.; Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, United States.; Harvard Medical School, Boston, United States.; Biological and Biomedical Sciences Program, Harvard Medical School, Boston, United States., Thornock AM; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Boston, United States.; Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, United States.; Harvard Medical School, Boston, United States.; Biological and Biomedical Sciences Program, Harvard Medical School, Boston, United States., Barbano J; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Boston, United States., Xifaras ME; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Boston, United States.; Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, United States.; Harvard Medical School, Boston, United States.; Immunology Program, Harvard Medical School, Boston, United States., Baron CS; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Boston, United States.; Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, United States.; Harvard Medical School, Boston, United States., Yang S; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Boston, United States.; Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, United States.; Harvard Medical School, Boston, United States., Koczirka K; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Boston, United States., McConnell AM; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Boston, United States.; Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, United States.; Harvard Medical School, Boston, United States., Zon LI; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Boston, United States.; Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, United States.; Harvard Medical School, Boston, United States.
Publikováno v:
ELife [Elife] 2024 Jun 14; Vol. 13. Date of Electronic Publication: 2024 Jun 14.
Autor:
Babu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Chen J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Robitschek E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Baron CS; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, 02115, USA., McConnell A; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, 02115, USA., Wu C; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, 02115, USA., Dedeilia A; Massachusetts General Hospital (MGH) Cancer Center, Boston, MA, 02114, USA., Sade-Feldman M; Massachusetts General Hospital (MGH) Cancer Center, Boston, MA, 02114, USA., Modhurima R; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, 02115, USA., Manos MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Chen KY; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, 02115, USA., Cox AM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Ludwig CG; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, 02115, USA., Yang J; Broad Institute of Massachusetts Institute of Technology (MIT), Cambridge, MA, 02142, USA.; MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, 02139, USA., Kellis M; Broad Institute of Massachusetts Institute of Technology (MIT), Cambridge, MA, 02142, USA.; MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, 02139, USA., Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Hacohen N; Massachusetts General Hospital (MGH) Cancer Center, Boston, MA, 02114, USA.; Broad Institute of Massachusetts Institute of Technology (MIT), Cambridge, MA, 02142, USA.; Harvard Medical School (HMS), Boston, MA, USA; Department of Immunology, HMS, Boston, MA, 02115, USA., Boland GM; Massachusetts General Hospital (MGH) Cancer Center, Boston, MA, 02114, USA., Abraham BJ; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA., Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Zon LI; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, 02115, USA., Insco ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Apr 26. Date of Electronic Publication: 2024 Apr 26.
Autor:
Rubin SA; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.; Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, MA., Baron CS; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA.; Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, MA., Pessoa Rodrigues C; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA.; Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, MA., Duran M; Department of Genome Sciences, University of Washington, Seattle, WA., Corbin AF; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA., Yang SP; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA., Trapnell C; Department of Genome Sciences, University of Washington, Seattle, WA., Zon LI; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.; Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, MA.; Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2022 Sep 05; Vol. 219 (9). Date of Electronic Publication: 2022 Aug 08.
Autor:
Battich N; Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, 3584 CT Utrecht, Netherlands. n.battich@hubrecht.eu a.vanoudenaarden@hubrecht.eu., Beumer J; Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, 3584 CT Utrecht, Netherlands., de Barbanson B; Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, 3584 CT Utrecht, Netherlands., Krenning L; Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, 3584 CT Utrecht, Netherlands., Baron CS; Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, 3584 CT Utrecht, Netherlands., Tanenbaum ME; Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, 3584 CT Utrecht, Netherlands., Clevers H; Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, 3584 CT Utrecht, Netherlands., van Oudenaarden A; Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, 3584 CT Utrecht, Netherlands. n.battich@hubrecht.eu a.vanoudenaarden@hubrecht.eu.
Publikováno v:
Science (New York, N.Y.) [Science] 2020 Mar 06; Vol. 367 (6482), pp. 1151-1156.
Autor:
Baron CS; Oncode Institute, Utrecht, Netherlands.; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, Utrecht, Netherlands.; University Medical Center Utrecht, Utrecht, Netherlands.; University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, Netherlands., van Oudenaarden A; Oncode Institute, Utrecht, Netherlands. a.vanoudenaarden@hubrecht.eu.; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, Utrecht, Netherlands. a.vanoudenaarden@hubrecht.eu.; University Medical Center Utrecht, Utrecht, Netherlands. a.vanoudenaarden@hubrecht.eu.; University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, Netherlands. a.vanoudenaarden@hubrecht.eu.
Publikováno v:
Nature reviews. Molecular cell biology [Nat Rev Mol Cell Biol] 2019 Dec; Vol. 20 (12), pp. 753-765. Date of Electronic Publication: 2019 Nov 05.
Autor:
Baron CS; Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Barve A; Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Muraro MJ; Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands; Single Cell Discoveries, Utrecht, the Netherlands., van der Linden R; Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Dharmadhikari G; Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center, Utrecht, the Netherlands., Lyubimova A; Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands., de Koning EJP; Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center, Utrecht, the Netherlands; Section of Nephrology and Section of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands., van Oudenaarden A; Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands. Electronic address: a.vanoudenaarden@hubrecht.eu.
Publikováno v:
Cell [Cell] 2019 Oct 03; Vol. 179 (2), pp. 527-542.e19.
Autor:
Baron CS; Hubrecht Institute-KNAW, University Medical Center Utrecht, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands., Kester L; Hubrecht Institute-KNAW, University Medical Center Utrecht, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands., Klaus A; Hubrecht Institute-KNAW, University Medical Center Utrecht, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands., Boisset JC; Hubrecht Institute-KNAW, University Medical Center Utrecht, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands., Thambyrajah R; CRUK Stem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Aderley Park, Aderley Edge, Macclesfield, SK10 4TG, UK., Yvernogeau L; Hubrecht Institute-KNAW, University Medical Center Utrecht, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands., Kouskoff V; Division of Developmental Biology and Medicine, The University of Manchester, Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK., Lacaud G; CRUK Stem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Aderley Park, Aderley Edge, Macclesfield, SK10 4TG, UK., van Oudenaarden A; Hubrecht Institute-KNAW, University Medical Center Utrecht, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands., Robin C; Hubrecht Institute-KNAW, University Medical Center Utrecht, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands. c.robin@hubrecht.eu.; Regenerative Medicine Center, University Medical Center Utrecht, 3584 EA, Utrecht, The Netherlands. c.robin@hubrecht.eu.
Publikováno v:
Nature communications [Nat Commun] 2018 Jun 28; Vol. 9 (1), pp. 2517. Date of Electronic Publication: 2018 Jun 28.
Autor:
Alemany A; Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands., Florescu M; Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands., Baron CS; Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands., Peterson-Maduro J; Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands., van Oudenaarden A; Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands.
Publikováno v:
Nature [Nature] 2018 Apr 05; Vol. 556 (7699), pp. 108-112. Date of Electronic Publication: 2018 Mar 28.
Autor:
van den Brink SC; Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.; University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, The Netherlands., Sage F; Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Vértesy Á; Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.; University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, The Netherlands., Spanjaard B; Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.; University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, The Netherlands.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin-Buch, Germany., Peterson-Maduro J; Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.; University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, The Netherlands., Baron CS; Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.; University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, The Netherlands., Robin C; Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.; University Medical Center Utrecht, Department of Cell Biology, Utrecht, The Netherlands., van Oudenaarden A; Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.; University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, The Netherlands.
Publikováno v:
Nature methods [Nat Methods] 2017 Sep 29; Vol. 14 (10), pp. 935-936.